Anti-AKD1A/ ANKDD1A functional antibody

Anti-AKD1A/ ANKDD1A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ANKDD1A/ANKDD1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0669-Ab-1/ GM-Tg-hg-SE0669-Ab-2Anti-Human ANKDD1A monoclonal antibodyHuman
GM-Tg-rg-SE0669-Ab-1/ GM-Tg-rg-SE0669-Ab-2Anti-Rat ANKDD1A monoclonal antibodyRat
GM-Tg-mg-SE0669-Ab-1/ GM-Tg-mg-SE0669-Ab-2Anti-Mouse ANKDD1A monoclonal antibodyMouse
GM-Tg-cynog-SE0669-Ab-1/ GM-Tg-cynog-SE0669-Ab-2Anti-Cynomolgus/ Rhesus macaque ANKDD1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0669-Ab-1/ GM-Tg-felg-SE0669-Ab-2Anti-Feline ANKDD1A monoclonal antibodyFeline
GM-Tg-cang-SE0669-Ab-1/ GM-Tg-cang-SE0669-Ab-2Anti-Canine ANKDD1A monoclonal antibodyCanine
GM-Tg-bovg-SE0669-Ab-1/ GM-Tg-bovg-SE0669-Ab-2Anti-Bovine ANKDD1A monoclonal antibodyBovine
GM-Tg-equg-SE0669-Ab-1/ GM-Tg-equg-SE0669-Ab-2Anti-Equine ANKDD1A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0669-Ab-1/ GM-Tg-hg-SE0669-Ab-2; GM-Tg-rg-SE0669-Ab-1/ GM-Tg-rg-SE0669-Ab-2;
GM-Tg-mg-SE0669-Ab-1/ GM-Tg-mg-SE0669-Ab-2; GM-Tg-cynog-SE0669-Ab-1/ GM-Tg-cynog-SE0669-Ab-2;
GM-Tg-felg-SE0669-Ab-1/ GM-Tg-felg-SE0669-Ab-2; GM-Tg-cang-SE0669-Ab-1/ GM-Tg-cang-SE0669-Ab-2;
GM-Tg-bovg-SE0669-Ab-1/ GM-Tg-bovg-SE0669-Ab-2; GM-Tg-equg-SE0669-Ab-1/ GM-Tg-equg-SE0669-Ab-2
Products NameAnti-ANKDD1A monoclonal antibody
Formatmab
Target NameANKDD1A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANKDD1A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0669-Ag-1Recombinant multi-species AKD1A/ ANKDD1A protein


    Target information

    Target IDGM-SE0669
    Target NameANKDD1A
    Gene ID348094,330963,100362785,712746,487598,101097244,112448539,100066607
    Gene Symbol and SynonymsA730067D02,A730067D02Rik,ANKDD1A,EG330963,Gm1473
    Uniprot AccessionQ495B1
    Uniprot Entry NameAKD1A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166839
    Target ClassificationN/A

    The target: ANKDD1A, gene name: ANKDD1A, also named as . Predicted to be involved in signal transduction. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.